FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940379717> ?p ?o ?g. }

• W2940379717 endingPage "8929" @default.
• W2940379717 startingPage "8918" @default.
• W2940379717 abstract "Valosin-containing protein (VCP), also known as p97, is an ATPase with diverse cellular functions, although the most highly characterized is targeting of misfolded or aggregated proteins to degradation pathways, including the endoplasmic reticulum–associated degradation (ERAD) pathway. However, how VCP functions in the heart has not been carefully examined despite the fact that human mutations in VCP cause Paget disease of bone and frontotemporal dementia, an autosomal dominant multisystem proteinopathy that includes disease in the heart, skeletal muscle, brain, and bone. Here we generated heart-specific transgenic mice overexpressing WT VCP or a VCPK524A mutant with deficient ATPase activity. Transgenic mice overexpressing WT VCP exhibit normal cardiac structure and function, whereas mutant VCP-overexpressing mice develop cardiomyopathy. Mechanistically, mutant VCP-overexpressing hearts up-regulate ERAD complex components and have elevated levels of ubiquitinated proteins prior to manifestation of cardiomyopathy, suggesting dysregulation of ERAD and inefficient clearance of proteins targeted for proteasomal degradation. The hearts of mutant VCP transgenic mice also exhibit profound defects in cardiomyocyte nuclear morphology with increased nuclear envelope proteins and nuclear lamins. Proteomics revealed overwhelming interactions of endogenous VCP with ribosomal, ribosome-associated, and RNA-binding proteins in the heart, and impairment of cardiac VCP activity resulted in aggregation of large ribosomal subunit proteins. These data identify multifactorial functions and diverse mechanisms whereby VCP regulates cardiomyocyte protein and RNA quality control that are critical for cardiac homeostasis, suggesting how human VCP mutations negatively affect the heart. Valosin-containing protein (VCP), also known as p97, is an ATPase with diverse cellular functions, although the most highly characterized is targeting of misfolded or aggregated proteins to degradation pathways, including the endoplasmic reticulum–associated degradation (ERAD) pathway. However, how VCP functions in the heart has not been carefully examined despite the fact that human mutations in VCP cause Paget disease of bone and frontotemporal dementia, an autosomal dominant multisystem proteinopathy that includes disease in the heart, skeletal muscle, brain, and bone. Here we generated heart-specific transgenic mice overexpressing WT VCP or a VCPK524A mutant with deficient ATPase activity. Transgenic mice overexpressing WT VCP exhibit normal cardiac structure and function, whereas mutant VCP-overexpressing mice develop cardiomyopathy. Mechanistically, mutant VCP-overexpressing hearts up-regulate ERAD complex components and have elevated levels of ubiquitinated proteins prior to manifestation of cardiomyopathy, suggesting dysregulation of ERAD and inefficient clearance of proteins targeted for proteasomal degradation. The hearts of mutant VCP transgenic mice also exhibit profound defects in cardiomyocyte nuclear morphology with increased nuclear envelope proteins and nuclear lamins. Proteomics revealed overwhelming interactions of endogenous VCP with ribosomal, ribosome-associated, and RNA-binding proteins in the heart, and impairment of cardiac VCP activity resulted in aggregation of large ribosomal subunit proteins. These data identify multifactorial functions and diverse mechanisms whereby VCP regulates cardiomyocyte protein and RNA quality control that are critical for cardiac homeostasis, suggesting how human VCP mutations negatively affect the heart." @default.
• W2940379717 created "2019-04-25" @default.
• W2940379717 creator A5010911855 @default.
• W2940379717 creator A5014111382 @default.
• W2940379717 creator A5015069844 @default.
• W2940379717 creator A5023514844 @default.
• W2940379717 creator A5052314302 @default.
• W2940379717 creator A5064270709 @default.
• W2940379717 creator A5075550603 @default.
• W2940379717 date "2019-05-01" @default.
• W2940379717 modified "2023-10-17" @default.
• W2940379717 title "Disruption of valosin-containing protein activity causes cardiomyopathy and reveals pleiotropic functions in cardiac homeostasis" @default.
• W2940379717 cites W1496748157 @default.
• W2940379717 cites W1528145391 @default.
• W2940379717 cites W1546139069 @default.
• W2940379717 cites W1611974981 @default.
• W2940379717 cites W1681625550 @default.
• W2940379717 cites W1965249601 @default.
• W2940379717 cites W1965286266 @default.
• W2940379717 cites W1967559627 @default.
• W2940379717 cites W1979042130 @default.
• W2940379717 cites W1981835453 @default.
• W2940379717 cites W1983633543 @default.
• W2940379717 cites W1989768108 @default.
• W2940379717 cites W1989831269 @default.
• W2940379717 cites W2000789682 @default.
• W2940379717 cites W2003079343 @default.
• W2940379717 cites W2007201048 @default.
• W2940379717 cites W2010862596 @default.
• W2940379717 cites W2011269026 @default.
• W2940379717 cites W2017764563 @default.
• W2940379717 cites W2024115241 @default.
• W2940379717 cites W2024138998 @default.
• W2940379717 cites W2033088972 @default.
• W2940379717 cites W2035349696 @default.
• W2940379717 cites W2038794428 @default.
• W2940379717 cites W2040550235 @default.
• W2940379717 cites W2042346825 @default.
• W2940379717 cites W2042514375 @default.
• W2940379717 cites W2043178567 @default.
• W2940379717 cites W2043997676 @default.
• W2940379717 cites W2044353042 @default.
• W2940379717 cites W2044585950 @default.
• W2940379717 cites W2044588236 @default.
• W2940379717 cites W2048143387 @default.
• W2940379717 cites W2051975755 @default.
• W2940379717 cites W2052618513 @default.
• W2940379717 cites W2056607803 @default.
• W2940379717 cites W2057608934 @default.
• W2940379717 cites W2060396343 @default.
• W2940379717 cites W2061673254 @default.
• W2940379717 cites W2066107559 @default.
• W2940379717 cites W2078644413 @default.
• W2940379717 cites W2079261384 @default.
• W2940379717 cites W2080378383 @default.
• W2940379717 cites W2092869829 @default.
• W2940379717 cites W2099208822 @default.
• W2940379717 cites W2103644580 @default.
• W2940379717 cites W2116170771 @default.
• W2940379717 cites W2126839598 @default.
• W2940379717 cites W2133328978 @default.
• W2940379717 cites W2133406524 @default.
• W2940379717 cites W2140608810 @default.
• W2940379717 cites W2141284487 @default.
• W2940379717 cites W2141756194 @default.
• W2940379717 cites W2144104591 @default.
• W2940379717 cites W2146181664 @default.
• W2940379717 cites W2146969978 @default.
• W2940379717 cites W2160741365 @default.
• W2940379717 cites W2162017609 @default.
• W2940379717 cites W2169883398 @default.
• W2940379717 cites W2171862076 @default.
• W2940379717 cites W2172163368 @default.
• W2940379717 cites W2204380040 @default.
• W2940379717 cites W2208922467 @default.
• W2940379717 cites W2236156346 @default.
• W2940379717 cites W2260339267 @default.
• W2940379717 cites W2299138801 @default.
• W2940379717 cites W2300083264 @default.
• W2940379717 cites W2311204218 @default.
• W2940379717 cites W2346720951 @default.
• W2940379717 cites W2410453457 @default.
• W2940379717 cites W2416403255 @default.
• W2940379717 cites W2530354305 @default.
• W2940379717 cites W2556695214 @default.
• W2940379717 cites W2742501476 @default.
• W2940379717 cites W2774010248 @default.
• W2940379717 cites W2801464337 @default.
• W2940379717 cites W2806222361 @default.
• W2940379717 cites W3133907395 @default.
• W2940379717 doi "https://doi.org/10.1074/jbc.ra119.007585" @default.
• W2940379717 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6552413" @default.
• W2940379717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31006653" @default.
• W2940379717 hasPublicationYear "2019" @default.
• W2940379717 type Work @default.
• W2940379717 sameAs 2940379717 @default.
• W2940379717 citedByCount "15" @default.
• W2940379717 countsByYear W29403797172020 @default.

• next